Patents Assigned to ILAb Co., Ltd.
  • NOVEL TNF ACTIVITY INHIBITOR COMPOUND, AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20230271925
    Abstract: The present invention relates to a novel TNF activity inhibitor compound and a pharmaceutically acceptable salt thereof, a method for prevention, alleviation or treatment comprising administering the compound of the present invention, a method for preparing the compound of the present invention, and a pharmaceutical composition comprising the compound.
    Type: Application
    Filed: June 28, 2021
    Publication date: August 31, 2023
    Applicant: ILAb Co., Ltd.
    Inventor: Kyung Yeon Park